Iron-deficiency anemia is the most common pathological condition seen in inflammatory bowel disease which has a negative impact on a patient’s quality of life. To treat iron deficiency anemia, iron replacement therapy is usually done with oral ferrous iron preparations. However, these compounds may have a poor bioavailability of ferrous salts with